Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Preventing biofilms of clinically relevant organisms using bacteriophage.

Donlan RM.

Trends Microbiol. 2009 Feb;17(2):66-72. doi: 10.1016/j.tim.2008.11.002. Epub 2009 Jan 21. Review.

PMID:
19162482
2.

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.

Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H, Imai S.

J Infect Chemother. 2005 Oct;11(5):211-9. Review.

PMID:
16258815
3.

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.

Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85. doi: 10.1586/eri.11.90. Review.

PMID:
21905786
4.

Biofilms and infection in dialysis patients.

Dasgupta MK.

Semin Dial. 2002 Sep-Oct;15(5):338-46. Review.

PMID:
12358638
5.

Biofilms in ear, nose, and throat infections: how important are they?

Vlastarakos PV, Nikolopoulos TP, Maragoudakis P, Tzagaroulakis A, Ferekidis E.

Laryngoscope. 2007 Apr;117(4):668-73. Review.

PMID:
17415138
6.

Bacteriophage host range and bacterial resistance.

Hyman P, Abedon ST.

Adv Appl Microbiol. 2010;70:217-48. doi: 10.1016/S0065-2164(10)70007-1. Epub 2010 Mar 6. Review.

PMID:
20359459
7.

Biofilm formation as microbial development.

O'Toole G, Kaplan HB, Kolter R.

Annu Rev Microbiol. 2000;54:49-79. Review.

PMID:
11018124
8.

Bacteriophage inspired antibiotics discovery against infection involved biofilm.

Fan X, Li W, Zheng F, Xie J.

Crit Rev Eukaryot Gene Expr. 2013;23(4):317-26. Review.

PMID:
24266847
9.

[Phage associated polysaccharide depolymerases - characteristics and application].

Maszewska A.

Postepy Hig Med Dosw (Online). 2015 Jun 16;69:690-702. doi: 10.5604/17322693.1157422. Review. Polish.

10.

[Biofilms].

Didilescu A.

Pneumologia. 2004 Jan-Mar;53(1):26-30. Review. Romanian.

PMID:
18210718
11.

The role of biofilms in otolaryngologic infections.

Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD.

Curr Opin Otolaryngol Head Neck Surg. 2004 Jun;12(3):185-90. Review.

PMID:
15167027
12.

Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.

Ryan EM, Gorman SP, Donnelly RF, Gilmore BF.

J Pharm Pharmacol. 2011 Oct;63(10):1253-64. doi: 10.1111/j.2042-7158.2011.01324.x. Epub 2011 Jul 6. Review.

PMID:
21899540
13.

[Biofilm and bacterial microrganisms in genito-urinary infections].

Mazzoli S.

Infez Med. 2009 Jun;17 Suppl 1:3-9. Review. Italian.

14.

Biofilm control with natural and genetically-modified phages.

Motlagh AM, Bhattacharjee AS, Goel R.

World J Microbiol Biotechnol. 2016 Apr;32(4):67. doi: 10.1007/s11274-016-2009-4. Epub 2016 Mar 1. Review.

PMID:
26931607
15.

Bacteriophages as an alternative strategy for fighting biofilm development.

Parasion S, Kwiatek M, Gryko R, Mizak L, Malm A.

Pol J Microbiol. 2014;63(2):137-45. Review.

16.

The interaction of phage and biofilms.

Sutherland IW, Hughes KA, Skillman LC, Tait K.

FEMS Microbiol Lett. 2004 Mar 12;232(1):1-6. Review.

17.

Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.

Viertel TM, Ritter K, Horz HP.

J Antimicrob Chemother. 2014 Sep;69(9):2326-36. doi: 10.1093/jac/dku173. Epub 2014 May 28. Review.

PMID:
24872344
18.

Biofilms and their role in otorhinolaryngological disease.

Macassey E, Dawes P.

J Laryngol Otol. 2008 Dec;122(12):1273-8. doi: 10.1017/S0022215108002193. Epub 2008 Apr 11. Review.

PMID:
18405407
19.

[Activity of antimicrobial agents on bacterial biofilms].

Rodríguez-Martínez JM, Pascual A.

Enferm Infecc Microbiol Clin. 2008 Feb;26(2):107-14. Review. Spanish.

PMID:
18341923
20.

New approaches for the characterization of prosthetic joint biofilms.

Donlan RM.

Clin Orthop Relat Res. 2005 Aug;(437):12-9. Review.

PMID:
16056020

Supplemental Content

Support Center